Page last updated: 2024-08-17

thymidine and isoxazoles

thymidine has been researched along with isoxazoles in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, AE; Bhuyan, BK; Blowers, CL; Kuentzel, SL; Neil, GL1
Burkhart, BM; Chattopadhyaya, J; Papchikhin, A; Sundaralingam, M1
Chong, AS; Finnegan, A; Foster, P; Gebel, H; Jiang, XL; Petraitis, EE; Sankary, HN; Williams, JW1
Cao, W; Morris, RE; Shorthouse, R; Silva, HT1
Morris, RE; Shorthouse, R; Silva, HT1
Kim, BH; Kim, SJ; Lee, JY1

Other Studies

6 other study(ies) available for thymidine and isoxazoles

ArticleYear
Studies of the biochemical pharmacology of the fermentation-derived antitumor agent, (alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
    Advances in enzyme regulation, 1978, Volume: 17

    Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Cell Line; Cell Survival; Female; Glutamine; Glycine; Isoxazoles; Leukemia L1210; Leukemia P388; Macromolecular Substances; Male; Mice; Oxazoles; Sex Factors; Thymidine; Uridine; Valine

1978
2',3'-Dideoxy-3'-C,2'-N-[(3R,5R)-5-ethoxy-carbonyl-2-methyl-1, 2-isoxazolidine]-ribothymidine.
    Acta crystallographica. Section C, Crystal structure communications, 1995, Jul-15, Volume: 51 ( Pt 7)

    Topics: Antiviral Agents; Crystallography, X-Ray; Isoxazoles; Molecular Structure; Thymidine

1995
Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.
    Transplantation proceedings, 1993, Volume: 25, Issue:1 Pt 1

    Topics: Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Polyenes; Sirolimus; T-Lymphocytes; Thymidine; Tritium

1993
Mechanism of action of leflunomide: in vivo uridine administration reverses its inhibition of lymphocyte proliferation.
    Transplantation proceedings, 1996, Volume: 28, Issue:6

    Topics: Animals; Dihydroorotate Dehydrogenase; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Male; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Rats; Rats, Inbred Lew; Thymidine; Uridine

1996
Single- and multiple-dose pharmacokinetics and pharmacodynamics of leflunomide's active metabolite A77 1726 in normal Lewis rats.
    Transplantation proceedings, 1996, Volume: 28, Issue:6

    Topics: Administration, Oral; Aniline Compounds; Animals; Crotonates; DNA; Dose-Response Relationship, Drug; Drug Administration Schedule; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Male; Metabolic Clearance Rate; Nitriles; Rats; Rats, Inbred Lew; Thymidine; Time Factors; Toluidines

1996
Design and synthesis of isoxazole and isoxazoline linkage for replacement of nucleotide phosphodiester.
    Bioorganic & medicinal chemistry letters, 1998, Jun-02, Volume: 8, Issue:11

    Topics: Drug Design; Isoxazoles; Oligonucleotides; Thymidine

1998